Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

What is the Immune System?

What is the Immune System?

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Humoral Immune Responses

Humoral Immune Responses

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Introduction to Innate and Adaptive Immunity

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nickel management by the accessory protein UreG during urease activation.

International journal of biological macromolecules·2026

Same author

Molecular Dynamics Workflows to Compute Large-Scale Sets of Absolute Binding Free Energies Aiding Drug Candidate and Binding Pose Selection.

Journal of chemical theory and computation·2026

Same author

Conformational response to ligand binding of TMPRSS2, a protease involved in SARS-CoV-2 infection: Insights through computational modeling.

Proteins·2023

Same author

Computational Study of Helicase from SARS-CoV-2 in RNA-Free and Engaged Form.

International journal of molecular sciences·2022

Same author

Fusobacterium necrophorum Bacteremia With Evidence of Cavitary Pulmonary Lesion.

Cureus·2021

Same author

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations.

International journal of molecular sciences·2020

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Published on: June 29, 2022

ImmunoGrid - the virtual human immune system project.

Andrew Emerson¹, Elda Rossi

¹High Performance Systems Division, CINECA, 40033 Casalecchio di Reno, Italy. a.emerson@cineca.it

Studies in Health Technology and Informatics

|May 4, 2007

Summary

The ImmunoGrid project is developing a complex immune system simulator using grid technologies. This infrastructure will aid in designing vaccines and immunotherapies, with validation through pre-clinical trials.

More Related Videos

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Jul 15, 2026

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Published on: June 29, 2022

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on: August 15, 2019

Area of Science:

Computational Biology
Immunology
Bioinformatics

Background:

The immune system simulation requires integrating molecular, cellular, and organ-level processes.
Existing models of the immune system need improvement and extension for greater complexity.

Purpose of the Study:

To establish an infrastructure for simulating the human immune system.
To support clinical applications like vaccine design, immunotherapies, and immunization protocol optimization.

Main Methods:

Developing advanced computational models of the immune system.
Utilizing grid technologies to manage the complexity of new models.
Integrating processes across molecular, cellular, and organ levels.

Main Results:

The project has completed the first phase, focusing on improving and extending existing immune system models.
The second phase is underway, concentrating on designing and implementing a human immune system simulator.

Conclusions:

Grid technologies are essential for handling the computational demands of complex immune system simulations.
The ImmunoGrid simulator will be validated using pre-clinical trials in mouse models.